Search

Klaus Stanzl Phones & Addresses

  • Rye, NY
  • 1 Laurel Rd, White Plains, NY 10605 (914) 761-1320
  • 10 Cottonwood Ln, White Plains, NY 10605 (914) 761-1320
  • New Iberia, LA
  • Morris Plains, NJ
  • Westchester, NY
  • 1 Laurel Rd, White Plains, NY 10605 (914) 557-0744

Work

Company: Symrise Jan 2011 Address: Holzminden, Germnay Position: President

Education

Degree: Ph.D. School / High School: Universität Stuttgart 1970 to 1979 Specialities: Chemistry

Emails

Industries

Chemicals

Resumes

Resumes

Klaus Stanzl Photo 1

President At Symrise

View page
Position:
President at Symrise
Location:
Stuttgart Area, Germany
Industry:
Chemicals
Work:
Symrise - Holzminden, Germnay since Jan 2011
President

Symrise Jul 2006 - Oct 2011
President

Symrise Mar 1997 - Jul 2006
President Cosmetic Ingredients

DRAGOCO (Now Symrise) 1997 - 2002
Vice President
Education:
Universität Stuttgart 1970 - 1979
Ph.D., Chemistry

Business Records

Name / Title
Company / Classification
Phones & Addresses
Klaus Stanzl
President
FLORASYNTH, INC
300 N St Attn: President, Teterboro, NJ 07608
300 N St, Teterboro, NJ 07608

Publications

Us Patents

Pharmacological Composition For Topical Administration

View page
US Patent:
56861028, Nov 11, 1997
Filed:
Jul 3, 1996
Appl. No.:
8/674851
Inventors:
Udo Gross - Berlin, DE
Joachim Roding - Wiesbaden, DE
Klaus Stanzl - White Plains NY
Leonhard Zastrow - Monaco, MC
Assignee:
Lancaster Group AG - Ludwigshafen
International Classification:
A61K 9127
A61K 700
US Classification:
424450
Abstract:
The invention relates to pharmaceutical compositions which are incorporated into the skin with the aid of novel microaggregates as carriers. The object of the invention is to make available pharmacological active compounds in a biologically and chemically inert carrier for therapeutic and diagnostic administration to the skin or for systemic administration, and in this way to make deeper penetration into the skin or transdermal transport possible. According to the invention, this is effected by means of a pharmaceutical composition for topical administration, which contains asymmetric lamellar aggregates, consisting of phospholipids, pharmacological active compounds and fluorocarbons or fluorocarbon mixtures, the proportion of fluorocarbon being in the range from 1 to 100% weight/volume, in a pharmaceutical excipient which is suitable for topical administration. Preparation is effected by emulsification of the appropriate constituents and use in ointments, creams, lotions, pastes, gels, powders or on a dressing or plaster or by means of a spray.

Functional Oxygenated Composition Containing Phospholipids And Fluorocarbon

View page
US Patent:
58855645, Mar 23, 1999
Filed:
Jun 17, 1997
Appl. No.:
8/877040
Inventors:
Leonhard Zastrow - Monaco, MC
Karin Golz - Monaco, MC
Klaus Stanzl - White Plains NY
Assignee:
Lancaster Group GmbH - Ludwigshafen
International Classification:
A61K 9133
A61K 3572
A61K 3574
US Classification:
424 74
Abstract:
A composition contains certain nutrients, active and protective substances, as well as an oxygen carrier, along with a process for preparing this composition and its use. The composition provides skin care preparation with a high oxygen content which also contain further nutrients, active and/or protective substances. The new functional oxygenated composition contains (a) phospholipids and oxygen-loaded fluorocarbon or fluorocarbon mixtures. The proportion of fluorocarbon lies in the 0. 2 to 100% by weight/volume range. The lipid fraction contains 30 to 99% by weight phosphatidylcholine in the form of asymmetric lamellar aggregates. The composition also contains (b) a product obtained by gentle disintegration of suspensions or dispersions of cells of plant substances, bacteria or yeasts by ultrasonic and/or high-pressure homogenization under up to 25 MPa; and (c) a cosmetic or dermatological carrier suitable for use on the skin. This composition is based for its oxygen content on the synergy between fluorocarbons and the disintegration products.

Preparation For Topical Use

View page
US Patent:
56415095, Jun 24, 1997
Filed:
Apr 30, 1996
Appl. No.:
8/640116
Inventors:
Udo Gross - Berlin, DE
Joachim Roding - Wiesbaden, DE
Klaus Stanzl - White Plains NY
Leonhard Zastrow - Monaco, MC
Assignee:
Lancaster Group AG - Ludwigshafen
International Classification:
A61K 9127
A61K 700
US Classification:
424450
Abstract:
The invention relates to a preparation for topical use, having light protection properties and in a special application form. In the known light protection agents containing the naturally occurring active compound melanin, the problem is inadequate transport of the melanin to its site of action. According to the invention, this problem is solved by a preparation for topical use which is characterised in that it contains melanin, dissolved or dispersed in one or more fluorocarbons, which are present as asymmetric lamellar phospholipid aggregates in an aqueous system together with a phospholipid, with a particle size of the aggregates in the range from 200 to 3000 nm.

Cosmetic Kaolin-Containing Preparation

View page
US Patent:
57165998, Feb 10, 1998
Filed:
May 9, 1997
Appl. No.:
8/836435
Inventors:
Karin Golz - Monaco, MC
Leonhard Zastrow - Monaco, MC
Klaus Stanzl - White Plains NY
Alfred Braunagel - Mainz, DE
Assignee:
Lancaster Group GmbH - Ludwigshafen
International Classification:
A61K 700
US Classification:
424 47
Abstract:
The invention involves a cosmetic preparation containing kaolin which may be employed as a mask, lotion, gel or cream with a non-sticky, non-plasticized consistency and with a content of white kaolin with a high proportion of kaolinite and spherical inorganic particles of a particle size of less than 5. mu. m, with a proportion of spherical particles in the kaolin mixture of 0. 5 to 10% by weight as well as a cosmetic skin care composition, in which the proportion of the kaolin/spherical particle mixture falls within the range of over 2 to 65% by weight of the composition as a whole. The viscosity of the composition with the proportion of kaolin/spherical particles is around 2000 to over 15,000 cps higher than a similar composition with kaolin only and without spherical particles, with the difference in viscosity increasing with the proportion of kaolin/spherical particles. The new, pleasantly soft preparation with an inhibitive effect with regard to inflammation permits high kaolin contents to be used to especially good effect in masks and gels.

Cosmetic With Condensates Of Plant And Animal Decomposition Products

View page
US Patent:
59165774, Jun 29, 1999
Filed:
Jul 18, 1997
Appl. No.:
8/875798
Inventors:
Karin Golz - Monaco, MC
Leonhard Zastrow - Monaco, MC
Klaus Stanzl - White Plains NY
Ulrich Klugel - Berlin, DE
Gunter Westphal - Berlin, DE
Leander Schobel - Berlin, DE
Assignee:
Lancaster Group GmbH - Ludwigshafen
International Classification:
A61K 3578
A61K 3520
A61K 706
A61K 748
US Classification:
424401
Abstract:
The invention concerns cosmetic agents with condensates of plant and animal decomposition products, which can be used in cosmetic body care and cleansing preparations and which, in addition to the emulsifying effect, have essential skin-care properties. The object of the invention is to prepare cosmetic products from plant and animal starting materials, said products having substantial portions of original biological structures but being modified to such an extent that they are cosmetically acceptable owing to their neutral smell and pale color. According to the invention, the cosmetic agent is a product of a direct and mild (20 to 55. degree. C. ; pH 7. 5 to 8. 5) decomposition of a biological starting material in an aqueous medium, subsequent condensation with a sub-stoechiometric amount of a C. sub. 10 to C. sub. 20 fatty acid halide or mixture and optionally subsequent etherification or esterification of the condensation product. The starting materials can be yeasts, yeast fractions, pulses, pulse fractions, pectins, pectin-containing masses, algae, algae fractions, animal milk, animal milk fractions and their mixtures, and contain helical natural substance components, enzyme structures and vitamin structures.

Stable Multiple Phase Emulsion Of The Type O.sub.1 /W/O.sub.2

View page
US Patent:
61068470, Aug 22, 2000
Filed:
Sep 5, 1997
Appl. No.:
8/924241
Inventors:
Louis Ferrero - Nice, FR
Karin Golz - Monaco, MC
Leonhard Zastrow - Monaco, MC
Klaus Stanzl - White Plains NY
Assignee:
Lancaster Group GmbH - Ludwigshafen
International Classification:
A61K 748
US Classification:
424401
Abstract:
The invention relates to a stable multiple phase emulsion of the O. sub. 1 /W/O. sub. 2 type with high proportions of the primary O. sub. 1 /W emulsion. The new emulsions have an emulsifier-free primary oil-in-water phase consisting of a viscoplastic aqueous gel containing the finely distributed inner oil droplets together with a gelling agent, wherein the thixotropic primary oil-in-water phase has a yield point in the range from 20 to 100 Pa and a plastic viscosity of 0. 01 to 0. 1 Pa. multidot. s and contains at least one lipophilic agent in the primary oil; and a secondary oil phase in which the primary oil-in-water phase is present together with a lipophilic emulsifier; and wherein the proportion of the inner oily phase is from 10 to 35 % by weight relative to the total weight of the emulsion. The higher proportions of the inner oily phase render possible higher proportions of organic sun protection agents with simultaneous avoidance of skin irritations.

Dermatological Agent For Assisting The Transport Of Oxygen In The Skin

View page
US Patent:
56373180, Jun 10, 1997
Filed:
Jul 3, 1996
Appl. No.:
8/674850
Inventors:
Udo Gross - Berlin, DE
Joachim Roding - Wiesbaden, DE
Klaus Stanzl - White Plains NY
Leonhard Zastrow - Monaco, MC
Assignee:
Lancaster Group AG - Ludwigshafen
International Classification:
A61K 9127
A61K 700
US Classification:
424450
Abstract:
The invention relates to a dermatological agent for assisting the transport of oxygen in the skin, a process for its preparation and the use thereof. The problem with the known dermatological agents is the inadequate supply of oxygen to the skin and the adjoining tissue. The object of the invention is therefore to get through the horny layer of the skin and the epidermis by penetration processes in order to increase the oxygen concentration in the dermal area and adjoining tissue and to activate metabolic processes. According to the invention, this is effected by means of a dermatological agent containing asymmetric lamellar aggregates, consisting of phospholipids and oxygen-laden fluorocarbon or fluorocarbon mixture, the amount of fluorocarbon being in the range from 0. 2 to 100% weight/volume, in a carrier which is suitable for dermatological use. Preparation is effected by emulsification of the corresponding constituents, and use in ointments, creams, lotions, waters, alcoholic extracts, pastes, powders, gels, tinctures or on dressings and plasters or in a spray.

Multi-Phase Light Screening Agent, Process For Its Production And For Its Application To The Skin

View page
US Patent:
59519673, Sep 14, 1999
Filed:
Jan 28, 1998
Appl. No.:
8/973605
Inventors:
Karin Golz - Monaco, MC
Leonhard Zastrow - Monaco, MC
Klaus Stanzl - White Plains NY
Jacques Gerbron - Menton, FR
Louis Ferrero - Nice, FR
Assignee:
Lancaster Group GmbH - Ludwigshafen
International Classification:
A61K 742
A61K 744
A61K 700
US Classification:
424 59
Abstract:
A multi-phase sunscreen agent, characterized by at least two phases that are liquid to pasty or gelatinous and separate from each other spontaneously within seconds to less than ten minutes after a brief and gentle mixing process lasting less than one minute without any essential application of force, where at least one phase contains a UV filter.
Klaus G Stanzl from Rye, NY, age ~72 Get Report